RGNX logo
REGENXBIO Inc.(RGNX)
Last print unknown agoAbout this dataData status
$7.15▲0.23 (3.25%)Stale · unknown old

RGNX EBITDA Margin

-79.73%TTM

Period ending:

RGNX FY EBITDA Margin%
RGNX FY EBITDA Margin216.64%-1586.48%
2013-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

RGNX ebitda margin history

EBITDA as a percentage of revenue. The available annual fiscal periods series contains 13 observations from Dec 31, 2013 to Dec 31, 2025.

Regenxbio Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
-78.1825%
-237.8888%
-265.3576%
-216.6726%
37.6505%
-62.6473%
-256.396%
42.1418%
-704.3106%
-1,411.9852%
-299.3015%
0%
-0.23%

Compare ebitda margin

All RGNX financial metrics · RGNX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.